Cited by 714Bone Metabolism and DiseasesTGF-β signaling in diseasesBone health and osteoporosis research

The DOI matches its Crossref record; 407 of the 408 references it cites were found in a registry or an index.

Transforming Growth Factor-β1 to the Bone

Janssens, Katrien, ten Dijke, Peter, Janssens, Sophie, Van Hul, Wim·2005·Endocrine Reviews

DOI 10.1210/er.2004-0001

Open this paper in CoChat — free account

Abstract

TGF-β1 is a ubiquitous growth factor that is implicated in the control of proliferation, migration, differentiation, and survival of many different cell types. It influences such diverse processes as embryogenesis, angiogenesis, inflammation, and wound healing. In skeletal tissue, TGF-β1 plays a major role in development and maintenance, affecting both cartilage and bone metabolism, the latter being the subject of this review. Because it affects both cells of the osteoblast and osteoclast lineage, TGF-β1 is one of the most important factors in the bone environment, helping to retain the balance between the dynamic processes of bone resorption and bone formation. Many seemingly contradictory reports have been published on the exact functioning of TGF-β1 in the bone milieu. This review provides an overall picture of the bone-specific actions of TGF-β1 and reconciles experimental discrepancies that have been reported for this multifunctional cytokine.

Integrity signals

Registry

Crossref · 10.1210/er.2004-0001

Cites

407 of 407 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

TGF-β SIGNAL TRANSDUCTION
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,571
Osteoclast differentiation and activation
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670 · cited 15×
“Runx2 binding sites are found in the promoters of several bone formation markers including collagen 1, ALP, osteopontin, RANKL, and osteocalcin (149).”
BackgroundInfluential
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Shi, Y., & Massagué, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00432-x · Cited by 5,860
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,498
Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases
Johnson, G. L., & Lapadat, R. (2002) · Science · doi:10.1126/science.1072682 · Cited by 4,295
Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation
Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L., & Karsenty, G. (1997) · Cell · doi:10.1016/s0092-8674(00)80257-3 · Cited by 4,246
Bone Resorption by Osteoclasts
Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962
The Novel Zinc Finger-Containing Transcription Factor Osterix Is Required for Osteoblast Differentiation and Bone Formation
Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J. M., Behringer, R. R., & de Crombrugghe, B. (2002) · Cell · doi:10.1016/s0092-8674(01)00622-5 · Cited by 3,608
The Transforming Growth Factor-Beta Family
Massagué, J. (1990) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.06.110190.003121 · Cited by 3,041
Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease
Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., et al. (1992) · Nature · doi:10.1038/359693a0 · Cited by 2,985
Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts
Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J.-I., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00369-6 · Cited by 2,701
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Käkönen, S.-M., Cordon‐Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,605
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
Massagué, J., Blain, S. W., & Lo, R. S. (2000) · Cell · doi:10.1016/s0092-8674(00)00121-5 · Cited by 2,391
TGF-β Signaling in Tumor Suppression and Cancer Progression
Derynck, R., Akhurst, R. J., & Balmain, A. (2001) · Nature Genetics · doi:10.1038/ng1001-117 · Cited by 2,275
Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.
Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M., & Karlsson, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.770 · Cited by 1,967
REGULATION OF IMMUNE RESPONSES BY TGF-β
Letterio, J. J., & Roberts, A. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.137 · Cited by 1,894
Genetic regulation of osteoclast development and function
Teitelbaum, S. L., & Ross, F. P. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1122 · Cited by 1,720
Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer
Siegel, P. M., & Massagué, J. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1208 · Cited by 1,626
Making sense of latent TGFβ activation
Annes, J. P., Munger, J. S., & Rifkin, D. B. (2002) · Journal of Cell Science · doi:10.1242/jcs.00229 · Cited by 1,624
Reaching a Genetic and Molecular Understanding of Skeletal Development
Karsenty, G., & Wagner, E. F. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00157-0 · Cited by 1,611
Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization.
Assoian, R. K., Komoriya, A., Meyers, C. A., Miller, D. M., & Sporn, M. B. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32345-7 · Cited by 1,597
Control of osteoblast function and regulation of bone mass
Harada, S.-I., & Rodan, G. A. (2003) · Nature · doi:10.1038/nature01660 · Cited by 1,478
Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1
McAllister, K. A., Grogg, K. M., Johnson, D. W., Gallione, C. J., Baldwin, M. A., Jackson, C. E., Helmbold, E. A., Markel, D. S., McKinnon, W. C., Murrel, J., et al. (1994) · Nature Genetics · doi:10.1038/ng1294-345 · Cited by 1,475
Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage [published erratum appears in J Cell Biol 1995 Feb;128(4):following 713]
Katagiri, T. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.127.6.1755 · Cited by 1,452
TGFβ2 knockout mice have multiple developmental defects that are non-overlapping with other TGFβ knockout phenotypes
Sanford, L. P., Ormsby, I., Groot, A. C. G.-D., Sariola, H., Friedman, R., Boivin, G. P., Cardell, E. L., & Doetschman, T. (1997) · Development · doi:10.1242/dev.124.13.2659 · Cited by 1,447
Mitogen-activated protein kinases in apoptosis regulation
Wada, T., & Penninger, J. M. (2004) · Oncogene · doi:10.1038/sj.onc.1207556 · Cited by 1,432 · cited 1×
“Although knockout and transgenic mouse models of numerous MAPK signaling intermediates are available (81) (for mouse models with a bone phenotype, see Refs.”
Background
Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank Interaction
Kobayashi, K., Takahashi, N., Jimi, E., Udagawa, N., Takami, M., Kotake, S., Nakagawa, N., Kinosaki, M., Yamaguchi, K., Shima, N., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.275 · Cited by 1,309
RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2 FOR TREATMENT OF OPEN TIBIAL FRACTURES: A PROSPECTIVE, CONTROLLED, RANDOMIZED STUDY OF FOUR HUNDRED AND FIFTY PATIENTS
GOVENDER, S., CSIMMA, C., GENANT, H. K., & VALENTIN-OPRAN, A. (2002) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200212000-00001 · Cited by 1,308
New insights into TGF-β–Smad signalling
ten Dijke, P., & Hill, C. S. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.03.008 · Cited by 1,176
Distinct endocytic pathways regulate TGF-β receptor signalling and turnover
Guglielmo, G. M. D., Roy, C. L., Goodfellow, A. F., & Wrana, J. L. (2003) · Nature Cell Biology · doi:10.1038/ncb975 · Cited by 1,152
The Osteoblast: A Sophisticated Fibroblast under Central Surveillance
Ducy, P. F., Schinke, T., & Karsenty, G. (2000) · Science · doi:10.1126/science.289.5484.1501 · Cited by 1,137
Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management
Lukert, B. P., & Raisz, L. G. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-5-352 · Cited by 1,063
Abnormal lung development and cleft palate in mice lacking TGF–β3 indicates defects of epithelial–mesenchymal interaction
Kaartinen, V., Voncken, J. W., Shuler, C. F., Warburton, D., Bu, D., Heisterkamp, N., & Groffen, J. (1995) · Nature Genetics · doi:10.1038/ng1295-415 · Cited by 1,042
Defective haematopoiesis and vasculogenesis in transforming growth factor-β1 knock out mice
Dickson, M. C., Martin, J. S., Cousins, F. M., Kulkarni, A. B., Karlsson, S., & Akhurst, R. J. (1995) · Development · doi:10.1242/dev.121.6.1845 · Cited by 1,029
IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology
Tat, S. K., Marc, P., Théoleyre, S., Heymann, D., & Fortun, Y. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2003.10.005 · Cited by 990
TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development
Yin, J. J., Selander, K. S., Chirgwin, J. M., Dallas, M., Grubbs, B. G., Wieser, R., Massagué, J., Mundy, G. R., & Guise, T. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3523 · Cited by 988
Cellular and molecular mechanisms of action of bisphosphonates
Rogers, M. J., Gordon, S., Benford, H. L., Coxon, F. P., Luckman, S. P., Mönkkönen, J., & Frith, J. C. (2000) · Cancer · doi:10.1002/1097-0142(20000615)88:12+ · Cited by 982
SARA, a FYVE Domain Protein that Recruits Smad2 to the TGFβ Receptor
Tsukazaki, T., Chiang, T., Davison, A. F., Attisano, L., & Wrana, J. L. (1998) · Cell · doi:10.1016/s0092-8674(00)81701-8 · Cited by 981
Osteogenic Protein-1 (Bone Morphogenetic Protein-7) in the Treatment of Tibial Nonunions
Friedlaender, G. E., Perry, C. R., Cole, J. D., Cook, S. D., Cierný, G., Muschler, G. F., Zych, G. A., Calhoun, J. H., LaForte, A. J., & Yin, S. (2001) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-200100002-00010 · Cited by 956
Transforming growth factor–β3 is required for secondary palate fusion
Proetzel, G., Pawlowski, S. A., Wiles, M. V., Yin, M., Boivin, G. P., Howles, P. N., Ding, J., Ferguson, M. W. J., & Doetschman, T. (1995) · Nature Genetics · doi:10.1038/ng1295-409 · Cited by 908
Betaglycan presents ligand to the TGFβ signaling receptor
López‐Casillas, F., Wrana, J. L., & Massagué, J. (1993) · Cell · doi:10.1016/0092-8674(93)90368-z · Cited by 892
Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF‐β
Yang, X. Y., Letterio, J. J., Lechleider, R. J., Chen, L., Hayman, R., Gu, H., Roberts, A. B., & Deng, C. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1280 · Cited by 889
Runx2 Is a Common Target of Transforming Growth Factor β1 and Bone Morphogenetic Protein 2, and Cooperation between Runx2 and Smad5 Induces Osteoblast-Specific Gene Expression in the Pluripotent Mesenchymal Precursor Cell Line C2C12
Lee, K., Kim, H., Li, Q., Chi, X., Ueta, C., Komori, T., Wozney, J. M., Kim, E., Choi, J.-Y., Ryoo, H., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.8783-8792.2000 · Cited by 867
Bone Morphogenetic Proteins, Their Antagonists, and the Skeleton
CANALIS, E. M., Economides, A. N., & Gazzerro, E. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0023 · Cited by 863
Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis.
Guise, T. A., Yin, J., Taylor, S. D., Kumagai, Y., Dallas, M., Boyce, B. F., Yoneda, T., & Mundy, G. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118947 · Cited by 849
Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells.
Cheifetz, S., Bellón, T., Calés, C., Vera, S., Bernabéu, C., Massagué, J., & Letarte, M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41732-2 · Cited by 836
Estrogen promotes apoptosis of murine osteoclasts mediated by TGF–β
Hughes, D. E., Dai, A., Tiffee, J. C., Li, H. H., Mundy, G. R., & Boyce, B. F. (1996) · Nature Medicine · doi:10.1038/nm1096-1132 · Cited by 813 · cited 3×
“, promotion of murine osteoclast apoptosis (261).”
Background
Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription
Zhang, Y., Feng, X.-H., & Derynck, R. (1998) · Nature · doi:10.1038/29814 · Cited by 809
Transforming growth factor-β in T-cell biology
Gorelik, L., & Flavell, R. A. (2002) · Nature Reviews Immunology · doi:10.1038/nri704 · Cited by 792
Genetic control of the circulating concentration of transforming growth factor type beta1
Grainger, D. J. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.1.93 · Cited by 754
TGF‐β receptor‐activated p38 MAP kinase mediates Smad‐independent TGF‐β responses
Yu, L., DeRouen, M. C., & Zhang, Y. E. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf366 · Cited by 738
Transforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrity
Pepper, M. S. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(96)00048-2 · Cited by 737
Differential Temporal Expression of Members of the Transforming Growth Factor β Superfamily During Murine Fracture Healing
Cho, T., Gerstenfeld, L. C., & Einhorn, T. A. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.3.513 · Cited by 736
AP-1 in mouse development and tumorigenesis
Jochum, W., Passegue, E. A., & Wagner, E. F. (2001) · Oncogene · doi:10.1038/sj.onc.1204389 · Cited by 734
Androgens and Bone
Vanderschueren, D., Vandenput, L., Boonen, S., Lindberg, M. K., Bouillon, R., & Ohlsson, C. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0003 · Cited by 717
Transforming Growth Factor-β Signaling Through the Smad Pathway: Role in Extracellular Matrix Gene Expression and Regulation
Verrecchia, F., & Mauviel, A. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01641.x · Cited by 683
TGF‐β induces fibronectin synthesis through a c‐Jun N‐terminal kinase‐dependent, Smad4‐independent pathway
Hocevar, B. A., Brown, T. L., & Howe, P. H. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1345 · Cited by 681
Two major Smad pathways in TGF‐β superfamily signalling
Miyazawa, K., Shinozaki, M., Hara, T., Furuya, T., & Miyazono, K. (2002) · Genes to Cells · doi:10.1046/j.1365-2443.2002.00599.x · Cited by 672
Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development.
Pelton, R. W., Saxena, B., Jones, M., Moses, H. L., & Gold, L. I. (1991) · The Journal of Cell Biology · doi:10.1083/jcb.115.4.1091 · Cited by 671
Smad3 Mutant Mice Develop Metastatic Colorectal Cancer
Zhu, Y., Richardson, J. A., Parada, L. F., & Graff, J. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81730-4 · Cited by 670
Genetic characterization and cloning of mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster.
Sekelsky, J. J., Newfeld, S. J., Raftery, L. A., Chartoff, E. H., & Gelbart, W. M. (1995) · Genetics · doi:10.1093/genetics/139.3.1347 · Cited by 659
TGF-β Receptor Type II Deficiency Results in Defects of Yolk Sac Hematopoiesis and Vasculogenesis
Oshima, M., Oshima, H., & Taketo, M. M. (1996) · Developmental Biology · doi:10.1006/dbio.1996.0259 · Cited by 651
Transforming growth factor βs and wound healing
O’Kane, S., & Ferguson, M. W. J. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(96)00120-3 · Cited by 634
Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone.
McCarthy, T. L., & CANALIS, E. M. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61587-x · Cited by 606
Smad2 role in mesoderm formation, left–right patterning and craniofacial development
Nomura, M., & Li, E. (1998) · Nature · doi:10.1038/31693 · Cited by 597
In VivoStimulation of Bone Formation by Transforming Growth Factor-β
Noda, M., & Camilliere, J. J. (1989) · Endocrinology · doi:10.1210/endo-124-6-2991 · Cited by 582
Osteoblast Programmed Cell Death (Apoptosis): Modulation by Growth Factors and Cytokines
Jilka, R. L., Weinstein, R. S., Bellido, T., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.5.793 · Cited by 578 · cited 1×
“Apoptosis of osteoblasts is blocked by TGF- 1 through maintenance of survival during transdifferentiation into osteocytes (93, 126, 127).”
Background
Abnormal angiogenesis but intact hematopoietic potential in TGF‐β type I receptor‐deficient mice
Larsson, J., Goumans, M., Sjöstrand, L. J., van Rooijen, M. A., Ward, D., Levéen, P., Xu, X., ten Dijke, P., Mummery, C. L., & Karlsson, S. (2001) · The EMBO Journal · doi:10.1093/emboj/20.7.1663 · Cited by 563
Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro.
Robey, P. G., Young, M. F., Flanders, K. C., Roche, N. S., Kondaiah, P., Reddi, A. H., Termine, J. D., Sporn, M. B., & Roberts, A. B. (1987) · The Journal of Cell Biology · doi:10.1083/jcb.105.1.457 · Cited by 550
Interdependent SMAD and JNK Signaling in Transforming Growth Factor-β-mediated Transcription
Engel, M. E., McDonnell, M. A., Law, B. K., & Moses, H. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37413 · Cited by 538
Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression
Stein, G. S., Lian, J. B., van Wijnen, A. J., Stein, J. L., Montecino, M. A., Javed, A., Zaidi, S. K., Young, D. W., Choi, J., & Pockwinse, S. M. (2004) · Oncogene · doi:10.1038/sj.onc.1207676 · Cited by 536
Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factor beta pathway components.
Savage‐Dunn, C., Das, P. K., Finelli, A., Townsend, S. R., Sun, C. Y., Baird, S. E., & Padgett, R. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.790 · Cited by 532
TGF‐β‐induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation
Alliston, T., Choy, L., Ducy, P., Karsenty, G., & Derynck, R. (2001) · The EMBO Journal · doi:10.1093/emboj/20.9.2254 · Cited by 526
A role of the latent TGF‐beta 1‐binding protein in the assembly and secretion of TGF‐beta 1.
Miyazono, K., Olofsson, A., Colosetti, P., & Heldin, C. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb08049.x · Cited by 509
Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-jun repression.
Shevde, N. K., Bendixen, A. C., Dienger, K. M., & Pike, J. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130200197 · Cited by 502
Purification and characterization of two cartilage-inducing factors from bovine demineralized bone.
Seyedin, S. M., Thomas, T. C., Thompson, A. Y., Rosen, D. M., & Piez, K. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.8.2267 · Cited by 498
The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryoPreprint
Sirard, C., de la Pompa, J. L., Elia, A., Itié, A., Mirtsos, C., Cheung, A., Hahn, S. A., Wakeham, A. C., Schwartz, L., Kern, S. E., et al. (1998) · Genes & Development · doi:10.1101/gad.12.1.107 · Cited by 498
A murine model of hereditary hemorrhagic telangiectasia
Bourdeau, A., Dumont, D., & Letarte, M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8088 · Cited by 471
Targeted Disruption of Smad3 Reveals an Essential Role in Transforming Growth Factor β-Mediated Signal Transduction
Datto, M., Frederick, J. P., Pan, L., Borton, A. J., Zhuang, Y., & Wang, X. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2495 · Cited by 470
A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA.
Bitzer, M., von Gersdorff, G., Liang, D., Dominguez-Rosales, A., Beg, A. A., Rojkind, M., & Böttinger, E. P. (2000) · PubMed Central · Cited by 453
Expression of transforming growth factor-beta 1 in specific cells and tissues of adult and neonatal mice.
Thompson, N. L., Flanders, K. C., Smith, J. M., Ellingsworth, L. R., Roberts, A. B., & Sporn, M. B. (1989) · The Journal of Cell Biology · doi:10.1083/jcb.108.2.661 · Cited by 448
Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction.
Roberts, A. B., Lamb, L. C., Newton, D., Sporn, M. B., Larco, J. E. D., & Todaro, G. J. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.6.3494 · Cited by 448
Convergence of Transforming Growth Factor-β and Vitamin D Signaling Pathways on SMAD Transcriptional Coactivators
Yanagisawa, J., Yanagi, Y., Masuhiro, Y., Suzawa, M., Watanabe, M., Kashiwagi, K., Toriyabe, T., Kawabata, M., Miyazono, K., & Kato, S. (1999) · Science · doi:10.1126/science.283.5406.1317 · Cited by 443
TGF-β receptor signaling
Derynck, R., & Feng, X. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00017-6 · Cited by 440
Tumor necrosis factor-α: molecular and cellular mechanisms in skeletal pathology
Nanes, M. S. (2003) · Gene · doi:10.1016/s0378-1119(03)00841-2 · Cited by 440
Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones.
Pfeilschifter, J., & Mundy, G. R. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.7.2024 · Cited by 434
Latent Transforming Growth Factor-β (TGF-β) Binding Proteins: Orchestrators of TGF-β Availability
Rifkin, D. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400029200 · Cited by 422
A mechanism of suppression of TGF–β/SMAD signaling by NF-κB/RelAPreprint
Bitzer, M., von Gersdorff, G., Liang, D., Dominguez-Rosales, A., Beg, A. A., Rojkind, M., & Böttinger, E. P. (2000) · Genes & Development · doi:10.1101/gad.14.2.187 · Cited by 422
Transforming Growth Factor-β–induced Mobilization of Actin Cytoskeleton Requires Signaling by Small GTPases Cdc42 and RhoA
Edlund, S., Landström, M., Heldin, C., & Aspenström, P. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.01-08-0398 · Cited by 418
Proteolysis of Latent Transforming Growth Factor-β (TGF-β)-binding Protein-1 by Osteoclasts
Dallas, S. L., Rosser, J. L., Mundy, G. R., & Bonewald, L. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111663200 · Cited by 414
BMP-2-induced Runx2 Expression Is Mediated by Dlx5, and TGF-β1 Opposes the BMP-2-induced Osteoblast Differentiation by Suppression of Dlx5 Expression
Lee, M., Kim, Y. J., Kim, H., Park, H.-D., Kang, A. H., Kyung, H., Sung, J.-H., Wozney, J. M., Kim, H., & Ryoo, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211386200 · Cited by 409
Mechanisms of Glucocorticoid Action in Bone
CANALIS, E., & DELANY, A. M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04204.x · Cited by 406
ANDROGENS DIRECTLY STIMULATE PROLIFERATION OF BONE CELLS IN VITRO
Kasperk, C. H., Wergedal, J. E., Farley, J. R., Linkhart, T. A., Turner, R. T., & Baylink (1989) · Endocrinology · doi:10.1210/endo-124-3-1576 · Cited by 398
Human Mast Cell Chymase and Leukocyte Elastase Release Latent Transforming Growth Factor-β1 from the Extracellular Matrix of Cultured Human Epithelial and Endothelial Cells
Taipale, J., Lohi, J., Saarinen, J., Kovanen, P. T., & Keski‐Oja, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.9.4689 · Cited by 396
Latent Transforming Growth Factor-β Binding Protein Domains Involved in Activation and Transglutaminase-dependent Cross-Linking of Latent Transforming Growth Factor-β
Nunes, I., Gleizes, P., Metz, C. N., & Rifkin, D. B. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.136.5.1151 · Cited by 395
Interleukin-11: a new cytokine critical for osteoclast development.
Girasole, G., Passeri, G., Jilka, R. L., & Manolagas, S. C. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117130 · Cited by 395
XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1–TAK1 in the BMP signaling pathway
Yamaguchi, K., Nagai, S., Ninomiya‐Tsuji, J., Nishita, M., Tamai, K., Irie, K., Ueno, N., Nishida, E., Shibuya, H., & Matsumoto, K. (1999) · The EMBO Journal · doi:10.1093/emboj/18.1.179 · Cited by 395
Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites
López‐Casillas, F., Payne, H., Andres, J., & Massagué, J. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.124.4.557 · Cited by 393
Two forms of transforming growth factor-β distinguished by multipotential haematopoietic progenitor cells
Ohta, M., Greenberger, J. S., Anklesaria, P. N., Bassols, A., & Massagué, J. (1987) · Nature · doi:10.1038/329539a0 · Cited by 392
Alpha and beta human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria.
Tashjian, A. H., Voelkel, E. F., Lazzaro, M., Singer, F. R., Roberts, A. B., Derynck, R., Winkler, M. E., & Levine, L. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.13.4535 · Cited by 381
Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype.
Erlebacher, A., & Derynck, R. (1996) · The Journal of Cell Biology · doi:10.1083/jcb.132.1.195 · Cited by 372
Effects of basic fibroblast growth factor on bone formation in vitro.
CANALIS, E. M., & McCarthy, T. L. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113490 · Cited by 372
A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer.
Dunning, A. M., Ellis, P. D., McBride, S. E., Kirschenlohr, H. L., Healey, C. S., Kemp, P. R., Luben, R., Chang-Claude, J. C., Mannermaa, A., Kataja, V. V., et al. (2003) · PubMed · Cited by 370
The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice
Yang, X. Y., Li, C., Xu, X., & Deng, C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3667 · Cited by 362
Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-β and bone morphogenetic protein
Lee, K., Hong, S.-H., & Bae, S. (2002) · Oncogene · doi:10.1038/sj.onc.1205937 · Cited by 353
Latent TGF-β Binding Proteins: Extracellular Matrix Association and Roles in TGF-β Activation
Hyytiäinen, M. M., Penttinen, C., & Keski‐Oja, J. (2004) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360490460933 · Cited by 351
Role of Ras and Mapks in TGFβ signaling
Mulder, K. M. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00026-x · Cited by 348
ATF-2 Is a Common Nuclear Target of Smad and TAK1 Pathways in Transforming Growth Factor-β Signaling
Sano, Y., Harada, J., Tashiro, S., Goto‐Mandeville, R., Maekawa, T., & Ishii, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8949 · Cited by 344
Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect
Geesink, R. G. T., Hoefnagels, N. H. M., & Bulstra, S. K. (1999) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.81b4.9311 · Cited by 344
Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice
Kaifu, T., Nakahara, J., Inui, M., Mishima, K., Momiyama, T., Kaji, M., Sugahara, A., Koito, H., Ujike, A., Nakamura, A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16923 · Cited by 342
Endogenous TGF‐β signaling suppresses maturation of osteoblastic mesenchymal cells
Maeda, S., Hayashi, M., Komiya, S., Imamura, T., & Miyazono, K. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600067 · Cited by 340
Effects of transforming growth factor β on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts
Harris, S. E., Bonewald, L. F., Harris, M. A., Sabatini, M., Dallas, S. L., Feng, J. Q., Ghosh‐Choudhury, N., Wozney, J. M., & Mundy, G. R. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090611 · Cited by 325
Smads bind directly to the Jun family of AP-1 transcription factors
Liberati, N. T., Datto, M., Frederick, J. P., Shen, X., Wong, C., Rougier-Chapman, E. M., & Wang, X. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.4844 · Cited by 323
Association of a Polymorphism of the Transforming Growth Factor-β1 Gene with Genetic Susceptibility to Osteoporosis in Postmenopausal Japanese Women
Yamada, Y., Miyauchi, A., Goto, J., Takagi, Y., Okuizumi, H., Kanematsu, M., Hase, M., Takai, H., Harada, A., & Ikeda, K. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.10.1569 · Cited by 318
Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta.
Keeton, M., Curriden, S. A., van Zonneveld, A. J., & Loskutoff, D. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54461-6 · Cited by 315
An AP-1 Binding Sequence Is Essential for Regulation of the Human α2(I) Collagen (COL1A2) Promoter Activity by Transforming Growth Factor-β
Chung, K. Y., Agarwal, A., Uitto, J., & Mauviel, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.6.3272 · Cited by 314
Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor smad2
Weinstein, M. B., Yang, X. Y., Li, C., Xu, X., Gotay, J., & Deng, C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9378 · Cited by 300
Transforming Growth Factor-β Stimulates the Production of Osteoprotegerin/Osteoclastogenesis Inhibitory Factor by Bone Marrow Stromal Cells
Takai, H., Kanematsu, M., Yano, K., Tsuda, E., Higashio, K., Ikeda, K., Watanabe, K., & Yamada, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.42.27091 · Cited by 299
Structural Basis of Smad2 Recognition by the Smad Anchor for Receptor Activation
Wu, G., Chen, Y., Ozdamar, B., Gyuricza, C. A., Chong, P. A., Wrana, J. L., Massagué, J., & Shi, Y. (2000) · Science · doi:10.1126/science.287.5450.92 · Cited by 298
Evidence for a Role of Rho-like GTPases and Stress-activated Protein Kinase/c-Jun N-terminal Kinase (SAPK/JNK) in Transforming Growth Factor β-mediated Signaling
Atfi, A., Djelloul, S., Chastre, E., Davis, R. J., & Gespach, C. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.3.1429 · Cited by 297
Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures.
Chenu, C., Pfeilschifter, J., Mundy, G. R., & Roodman, G. D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.15.5683 · Cited by 295
The role of prostaglandins in the regulation of bone metabolism.
Kawaguchi, H., Pilbeam, C. C., Harrison, J. R., & Raisz, L. G. (1995) · PubMed · Cited by 293
GADD34–PP1c recruited by Smad7 dephosphorylates TGFβ type I receptor
Shi, W., Sun, C., He, B., Xiong, W., Shi, X., Yao, D., & Cao, X. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200307151 · Cited by 289
Activation of the bone-derived latent TGF beta complex by isolated osteoclasts
Oreffo, R. O. C., Mundy, G. R., Seyedin, S. M., & Bonewald, L. F. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92795-2 · Cited by 285
Molecular Events in the Processing of Recombinant Type 1 Pre-Pro-Transforming Growth Factor Beta to the Mature Polypeptide
Gentry, L. E., Lioubin, M. N., Purchio, A. F., & Marquardt, H. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.10.4162 · Cited by 284
Effect of platelet-derived growth factor on tibial osteotomies in rabbits
Nash, T., Howlett, C. R., Martin, C., Steele, J. G., Johnson, K. A., & Hicklin, D. J. (1994) · Bone · doi:10.1016/8756-3282(94)90709-9 · Cited by 277
Regulation of Bovine Bone Cell Proliferation by Fibroblast Growth Factor and Transforming Growth Factorβ
Globus, R. K., Patterson‐Buckendahl, P., & Gospodarowicz, D. (1988) · Endocrinology · doi:10.1210/endo-123-1-98 · Cited by 266
Parathyroid hormone: a double-edged sword for bone metabolism
Qin, L., Raggatt, L. J., & Partridge, N. C. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.01.006 · Cited by 264
Modulation of Transforming Growth Factor-βProduction in Normal Human Osteoblast-Like Cells by 17β-Estradiol and Parathyroid Hormone
Oursler, M. J., CORTESE, C., Keeting, P. E., Anderson, M. A., Bonde, S. K., Riggs, B. L., & Spelsberg, T. C. (1991) · Endocrinology · doi:10.1210/endo-129-6-3313 · Cited by 263
Transforming growth factor beta inhibits bone resorption in fetal rat long bone cultures.
Pfeilschifter, J., Seyedin, S. M., & Mundy, G. R. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113647 · Cited by 261
The Smad pathway
Wrana, J. L., & Attisano, L. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00024-6 · Cited by 261
Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene
Baltzer, A. W. A., Lattermann, C. M., Whalen, J. D., Wooley, P. H., Weiss, K. R., Grimm, M. J., Ghivizzani, S. C., Robbins, P. D., & Evans, C. H. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301166 · Cited by 260
Functions of AP1 (Fos/Jun) in bone development
Wagner, E. F. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.suppl_2.ii40 · Cited by 260
Regulation of the TGFβ signalling pathway by ubiquitin-mediated degradation
Izzi, L., & Attisano, L. (2004) · Oncogene · doi:10.1038/sj.onc.1207412 · Cited by 259
ß-Arrestin 2 Mediates Endocytosis of Type III TGF-ß Receptor and Down-Regulation of Its Signaling
Chen, W., Kirkbride, K. C., How, T., Nelson, C. D., Mo, J., Frederick, J. P., Wang, X., Lefkowitz, R. J., & Blobe, G. C. (2003) · Science · doi:10.1126/science.1083195 · Cited by 258
Disruption of the gene encoding the latent transforming growth factor-β binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancerPreprint
Sterner‐Kock, A., Thorey, I. S., Koli, K. M., Wempe, F., Otte, J., Bangsow, T., Kuhlmeier, K., Kirchner, T., Jin, S., Keski‐Oja, J., et al. (2002) · Genes & Development · doi:10.1101/gad.229102 · Cited by 256
Cross-talk between Transforming Growth Factor-β and Estrogen Receptor Signaling through Smad3
Matsuda, T., Yamamoto, T., Muraguchi, A., & Saatcioglu, F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105316200 · Cited by 255
Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.
Lee, M. H., Javed, A., Kim, H. J., Shin, H. I., Gutierrez, S., Choi, J. Y., Rosen, V., Stein, J. L., van Wijnen, A. J., Stein, G. S., et al. (1999) · PubMed · doi:10.1002/(sici)1097-4644(19990401)73:1&lt;114::aid-jcb13&gt;3.0.co;2-m · Cited by 252
Bone Morphogenetic Protein 2 Stimulates Osteoclast Differentiation and Survival Supported by Receptor Activator of Nuclear Factor-κB Ligand
Itoh, K., Udagawa, N., Katagiri, T., Iemura, S., Ueno, N., Yasuda, H., Higashio, K., Quinn, J. M. W., Gillespie, M. T., Martin, T. J., et al. (2001) · Endocrinology · doi:10.1210/endo.142.8.8300 · Cited by 250
Domain-specific mutations in TGFB1 result in Camurati-Engelmann disease
Kinoshita, A., Saito, T., Tomita, H., Makita, Y., Yoshida, K., Ghadami, M., Yamada, K., Kondo, S., Ikegawa, S., Nishimura, G., et al. (2000) · Nature Genetics · doi:10.1038/79128 · Cited by 249
Matrix Metalloproteinase-dependent Activation of Latent Transforming Growth Factor-β Controls the Conversion of Osteoblasts into Osteocytes by Blocking Osteoblast Apoptosis
Karsdal, M. A., Larsen, L., Engsig, M. T., Lou, H., Ferreras, M., Lochter, A., Delaissé, J., & Foged, N. T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207205200 · Cited by 249
Vitamin D and bone
Suda, T., Ueno, Y., Fujii, K., & Shinki, T. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10331 · Cited by 248
Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture
Qu, Q., Perälä-Heape, M., Kapanen, A. I., Dahllund, J., Salo, J., Väänänen, H. K., & Härkönen, P. L. (1998) · Bone · doi:10.1016/s8756-3282(97)00276-7 · Cited by 243
Combined effects of insulin-like growth factor-1 and transforming growth factor-β1 on periosteal mesenchymal cells during chondrogenesis
Fukumoto, T., Sperling, J. W., Sanyal, A., Fitzsimmons, J. S., Reinholz, G. G., Conover, C. A., & O’Driscoll, S. W. (2002) · Osteoarthritis and Cartilage · doi:10.1053/joca.2002.0869 · Cited by 241
Heart and Liver Defects and Reduced Transforming Growth Factor β2 Sensitivity in Transforming Growth Factor β Type III Receptor-Deficient Embryos
Stenvers, K. L., Tursky, M. L., Harder, K. W., Kountouri, N., Amatayakul‐Chantler, S., Grail, D., Small, C. G., Weinberg, R. A., Sizeland, A. M., & Zhu, H. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.12.4371-4385.2003 · Cited by 239
Signal Transductions Induced by Bone Morphogenetic Protein-2 and Transforming Growth Factor-β in Normal Human Osteoblastic Cells
Lai, C.-F., & Cheng, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200794200 · Cited by 239
Differential effects of transforming growth factor-beta on the synthesis of extracellular matrix proteins by normal fetal rat calvarial bone cell populations.
Wrana, J. L., Maeno, M., Hawrylyshyn, B., Yao, K., Domenicucci, C., & Sodek, J. (1988) · The Journal of Cell Biology · doi:10.1083/jcb.106.3.915 · Cited by 237
The Comparative Role of Activator Protein 1 and Smad Factors in the Regulation of Timp-1 and MMP-1 Gene Expression by Transforming Growth Factor-β1
Hall, M.-C., Young, D. A., Waters, J. G., Rowan, A. D., Chantry, A., Edwards, D. R., & Clark, I. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212334200 · Cited by 237
Type 1 Transforming Growth Factor Beta: Amplified Expression and Secretion of Mature and Precursor Polypeptides in Chinese Hamster Ovary Cells
Gentry, L. E., Webb, N. R., Lim, G., Brunner, A. M., Ranchalis, J., Twardzik, D. R., Lioubin, M. N., Marquardt, H., & Purchio, A. F. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.10.3418-3427.1987 · Cited by 236
In vivo effects of human recombinant transforming growth factor β on bone turnover in normal mice
Marcelli, C., Yates, A. J., & Mundy, G. R. (1990) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650051013 · Cited by 236
Osteoblastic Responses to TGF-β during Bone Remodeling
Erlebacher, A., Filvaroff, E. H., Ye, J., & Derynck, R. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.7.1903 · Cited by 234
Genetic control of skeletal development
Wagner, E. F., & Karsenty, G. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00228-8 · Cited by 229
Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes
Park, J., Ries, J., Gelse, K., Kloss, F. R., von der Mark, K., Wiltfang, J., Neukam, F. W., & Schneider, H. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301960 · Cited by 228
Anabolic Therapy for Osteoporosis
Rosen, C. J., & Bilezikian, J. P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7366 · Cited by 226
Transforming growth factor beta is a potent inhibitor of interleukin 1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action.
Dubois, C. M., Ruscetti, F. W., Palaszynski, E. W., Falk, L. A., Oppenheim, J. J., & Keller, J. R. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.172.3.737 · Cited by 225
Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity
Kanatani, M., Sugimoto, T., Kaji, H., Kobayashi, T., Nishiyama, K., Fukase, M., Kumegawa, M., & Chihara, K. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650101110 · Cited by 225
Multiple Extracellular Signals Promote Osteoblast Survival and Apoptosis1
Hill, P. A., Tumber, A., & Meikle, M. C. (1997) · Endocrinology · doi:10.1210/endo.138.9.5370 · Cited by 220
Transforming growth factor-β enhances fracture healing in rabbit tibiae
Lind, M., Schumacker, B., Søballé, K., Keller, J. O., Melsen, F., & Bünger, C. E. (1993) · Acta Orthopaedica Scandinavica · doi:10.3109/17453679308993691 · Cited by 217
Regulation of differentiation by TFG-β
Moses, H. L., & Serra, R. A. (1996) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(96)80087-6 · Cited by 216
A sequence variation: 713-8delC in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women
Langdahl, B. L., Knudsen, J., Jensen, H. K., Gregersen, N. V., & Eriksen, E. F. (1997) · Bone · doi:10.1016/s8756-3282(96)00363-8 · Cited by 216
Transforming growth factor‐beta modulates the expression of osteoblast and chondroblast phenotypes in vitro
Rosen, D. M., Stempien, S. A., Thompson, A. Y., & Seyedin, S. M. (1988) · Journal of Cellular Physiology · doi:10.1002/jcp.1041340304 · Cited by 215
Opposite effects of bone morphogenetic protein-2 and transforming growth factor-β1 on osteoblast differentiation
Spinella-Jaegle, S., Roman‐Roman, S., Faucheu, C., Dunn, F. W., Kawai, S., Gallea, S., Stiot, V., Blanchet, A., Courtois, B., Baron, R., et al. (2001) · Bone · doi:10.1016/s8756-3282(01)00580-4 · Cited by 214
Recombinant Human Basic Fibroblast Growth Factor Accelerates Fracture Healing by Enhancing Callus Remodeling in Experimental Dog Tibial Fracture
Nakamura, T., Hara, Y., TAGAWA, M., Tamura, M., Yuge, T., Fukuda, H., & Nigi, H. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.6.942 · Cited by 213
Inhibition of TGF-β receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass
Filvaroff, E. H., Erlebacher, A., Ye, J., Gitelman, S. E., Lotz, J. C., Heilman, M., & Derynck, R. (1999) · Development · doi:10.1242/dev.126.19.4267 · Cited by 212
Elucidation of Smad Requirement in Transforming Growth Factor-β Type I Receptor-induced Responses
Itoh, S., Thorikay, M., Kowanetz, M., Moustakas, A., Itoh, F., Heldin, C., & ten Dijke, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208258200 · Cited by 211
Mutations in the gene encoding the latency-associated peptide of TGF-β1 cause Camurati-Engelmann disease
Janssens, K., Gershoni‐Baruch, R., Guañabens, N., Migone, N., Ralston, S. H., Bonduelle, M., Lissens, W., Maldergem, L. V., Vanhoenacker, F. M. H. M., Verbruggen, L., et al. (2000) · Nature Genetics · doi:10.1038/81563 · Cited by 210
Self-citation
Enhancement of bone ingrowth by transforming growth factor-beta.
Sumner, D. R., Turner, T. M., Purchio, A. F., Gombotz, W. R., Urban, R. M., & Galante, J. O. (1995) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-199508000-00001 · Cited by 209
Structural Basis of Heteromeric Smad Protein Assembly in TGF-β Signaling
Chacko, B. M., Qin, B. Y., Tiwari, A., Shi, G., Lam, S. S., Hayward, L. J., deCaestecker, M. P., & Lin, K. F. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.07.016 · Cited by 208
Hierarchical model of gene regulation by transforming growth factor β
Yang, Y.-C., Piek, E., Zavadil, J., Liang, D., Xie, D., Heyer, J., Pavlidis, P., Kucherlapati, R., Roberts, A. B., & Böttinger, E. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834070100 · Cited by 206
Coordinate occupancy of AP-1 sites in the vitamin D-responsive and CCAAT box elements by Fos-Jun in the osteocalcin gene: model for phenotype suppression of transcription.
Owen, T. A., Bortell, R., Yocum, S. A., Smock, S. L., Zhang, M., Abate, C., Shalhoub, V., D, N. A. M., Wright, K. L., & van Wijnen, A. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.24.9990 · Cited by 204
Differentiation and Cell Surface Expression of Transforming Growth Factor-β Receptors Are Regulated by Interaction with Matrix Collagen in Murine Osteoblastic Cells
Takeuchi, Y., Nakayama, K., & Matsumoto, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.7.3938 · Cited by 202
Release of transforming growth factor-beta 1 from the pericellular matrix of cultured fibroblasts and fibrosarcoma cells by plasmin and thrombin.
Taipale, J., Koli, K., & Keski‐Oja, J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74051-4 · Cited by 201
Transcriptional regulation of osteopontin production in rat osteosarcoma cells by type beta transforming growth factor.
Noda, M., Yoon, K., Prince, C. W., Butler, W. T., & Rodan, G. A. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68331-0 · Cited by 200
Vitamin D Control of Osteoblast Function and Bone Extracellular Matrix Mineralization
van Leeuwen, J. P. T. M., van Driel, M., van den Bemd, G. J. C. M., & Pols, H. A. P. (2001) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v11.i1-3.100 · Cited by 199
The insulin-like growth factor system and the coupling of formation to resorption
Hayden, J. M., Mohan, S., & Baylink, D. J. (1995) · Bone · doi:10.1016/8756-3282(95)00186-h · Cited by 199
A role for TGFβ1 in osteoclast differentiation and survival
Fuller, K., Lean, J. M., Bayley, K. E., Wani, M. R., & Chambers, T. J. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.13.2445 · Cited by 197
Human Platelet-Derived Transforming Growth Factor-βStimulates Parameters of Bone Growth in Fetal Rat Calvariae*
Massagué, J., & CANALIS, E. M. (1986) · Endocrinology · doi:10.1210/endo-119-5-2306 · Cited by 193
Critical Role of Smads and AP-1 Complex in Transforming Growth Factor-β-dependent Apoptosis
Yamamura, Y., Hua, X., Bergelson, S., & Lodish, H. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006023200 · Cited by 191
The latent transforming growth factor β binding protein (LTBP) family
Öklü, R., & Hesketh, R. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3520601 · Cited by 189
Transforming Growth Factor-β Stimulates Bone Matrix Apposition and Bone Cell Replication in Cultured Fetal Rat Calvariae*
Hock, J. M., & CANALIS, E. M. (1990) · Endocrinology · doi:10.1210/endo-126-1-421 · Cited by 189
Activation of the Hematopoietic Progenitor Kinase-1 (HPK1)-dependent, Stress-activated c-Jun N-terminal Kinase (JNK) Pathway by Transforming Growth Factor β (TGF-β)-activated Kinase (TAK1), a Kinase Mediator of TGF β Signal Transduction
Wang, W., Zhou, G., Hu, M. C. ‐., Yao, Z., & Tan, T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22771 · Cited by 188
Type β transforming growth factor (TGFβ) regulation of alkaline phosphatase expression and other phenotype‐related mRNAs in osteoblastic rat osteosarcoma cells
Noda, M., & Rodan, G. A. (1987) · Journal of Cellular Physiology · doi:10.1002/jcp.1041330303 · Cited by 188
A role for MEK kinase 1 in TGF‐β/activin‐induced epithelium movement and embryonic eyelid closure
Zhang, L., Wang, W., Hayashi, Y., Jester, J. V., Birk, D. E., Gao, M., Liu, C., Kao, W. W. ‐., Karin, M., & Xia, Y. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg440 · Cited by 184
Roles of stromal cell RANKL, OPG, and M‐CSF expression in biphasic TGF‐β regulation of osteoclast differentiation
Karst, M., Gorny, G., Galvin, R. J. S., & Oursler, M. J. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20036 · Cited by 184 · cited 2×
“TGF- 1 of M-CSF expression, this results in inhibition of osteoclast differentiation (166).”
Background
Recombinant human interferon-gamma inhibits formation of human osteoclast-like cells.
Takahashi, N., Mundy, G. R., & Roodman, G. D. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.11.3544 · Cited by 182
Hypoxia impairs cell fusion and differentiation process in human cytotrophoblast, in vitro
Alsat, E., Wyplosz, P., Malassiné, A., Guibourdenche, J., Porquet, D., Nessmann, C., & Evain‐Brion, D. (1996) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199608)168:2 · Cited by 182
Platelet-derived growth factor enhances bone cell replication, but not differentiated function of osteoblasts.
Hock, J. M., & CANALIS, E. M. (1994) · Endocrinology · doi:10.1210/endo.134.3.8119182 · Cited by 179
The Loss of Smad3 Results in a Lower Rate of Bone Formation and Osteopenia Through Dysregulation of Osteoblast Differentiation and Apoptosis
Borton, A. J., Frederick, J. P., Datto, M., Wang, X.-F., & Weinstein, R. S. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.10.1754 · Cited by 179
Transforming growth factor-beta 1, -beta 2, and -beta 3 secreted by a human glioblastoma cell line. Identification of small and different forms of large latent complexes.
Olofsson, A., Miyazono, K., Kanzaki, T., Colosetti, P., Engström, U., & Heldin, C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41801-7 · Cited by 178
Chemotactic response of osteoblastlike cells to transforming growth factorβ
Pfeilschifter, J., Wolf, O. K., Naumann, A., Minne, H. W., Mundy, G. R., & Ziegler, R. (1990) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650050805 · Cited by 176
Conditional deletion of the TGF-β type II receptor in Col2a expressing cells results in defects in the axial skeleton without alterations in chondrocyte differentiation or embryonic development of long bones
Baffi, M. O., Slattery, E., Sohn, P., Moses, H. L., Chytil, A. M., & Serra, R. A. (2004) · Developmental Biology · doi:10.1016/j.ydbio.2004.08.027 · Cited by 175
TGF-β1 induces bone closure of skull defects: Temporal dynamics of bone formation in defects exposed to rhTGF-β1
Beck, L. S., Amento, E. P., Xu, Y., Deguzman, L., Lee, W. P., Nguyen, T. H., & Gillett, N. A. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080614 · Cited by 175
Estrogen prevents bone loss through transforming growth factor β signaling in T cells
Gao, Y., Qian, W.-P., Dark, K., Toraldo, G., Lin, A., Guldberg, R. E., Flavell, R. A., Weitzmann, M. N., & Pacifici, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404888101 · Cited by 175
Characterization and autoregulation of latent transforming growth factor beta (TGF beta) complexes in osteoblast-like cell lines. Production of a latent complex lacking the latent TGF beta-binding protein.
Dallas, S. L., Park-Snyder, S., Miyazono, K., Twardzik, D. R., Mundy, G. R., & Bonewald, L. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37449-5 · Cited by 171
Tumor Necrosis Factor-α Inhibits Transforming Growth Factor-β /Smad Signaling in Human Dermal Fibroblasts via AP-1 Activation
Verrecchia, F., Pessah, M., Atfi, A., & Mauviel, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005310200 · Cited by 170
Enhanced expression of TGF-β and c-fos mRNAs in the growth plates of developing human long bones
Sandberg, M., Vuorio, T. K., Hirvonen, H., Alitalo, K. K., & Vuorio, E. (1988) · Development · doi:10.1242/dev.102.3.461 · Cited by 170
Studies of the Mechanism by which Androgens Enhance Mitogenesis and Differentiation in Bone Cells*
Kasperk, C. H., Fitzsimmons, R. J., Strong, D. D., Mohan, S., Jennings, J. C., Wergedal, J. E., & Baylink, D. J. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-5-1322 · Cited by 168
The Smads.
Attisano, L., & Lee-Hoeflich, S. T. (2001) · Genome biology · doi:10.1186/gb-2001-2-8-reviews3010 · Cited by 166
Glucocorticoid regulation of transforming growth factor beta 1 activity and binding in osteoblast-enriched cultures from fetal rat bone.
Centrella, M., McCarthy, T. L., & CANALIS, E. M. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.9.4490 · Cited by 164
Targeted Disruption in Murine Cells Reveals Variable Requirement for Smad4 in Transforming Growth Factor β-related Signaling
Sirard, C., Kim, S., Mirtsos, C., Tadich, P., Hoodless, P. A., Itié, A., Maxson, R. E., Wrana, J. L., & Mak, T. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.3.2063 · Cited by 161

Flagged first, then by citations

1 of the 408 references couldn’t be matched to a known paper.

Research works printed but not linked: 6

Mumm, 2001, Camurati-Engelmann disease: new mutations in the latency-associated peptide of the transforming growth factor β-1 gene, J Bone Miner Res, 16, S223
Wells, 2001, Polymorphisms in the transforming growth factor-1 and bone mass and bone loss, Bone, 28, S131
Prince, 2002, Effect of the TGF-β T869C and the CYP119 TTTA repeat polymorphisms on bone mineral density and prevalent fracture in elderly women, J Bone Miner Res, 17, S422
Kim, 2000, T/C polymorphism of the TGF-β1 gene is not associated with quantitative ultrasound values of calcaneus in Korean postmenopausal women in Chung-Up district, J Bone Miner Res, 15, S362
Hong, 2003, Lack of association of transforming growth factor β 1 T29→C gene polymorphism with calcaneal quantitative ultrasound parameters and plasma TGF-β1 levels in postmenopausal Korean women., Calcif Tissue Int, 72, S418
Mundy, 1991, The effects of TGF-β on bone., Ciba Found Symp, 157, 137

Sorted by citations

TGF-β1–induced migration of bone mesenchymal stem cells couples bone resorption with formation
Tang, Y., Wu, X., Lei, W., Pang, L., Wan, C., Shi, Z., Zhao, L., Nagy, T. R., Peng, X., Hu, J., et al. (2009) · Nature Medicine · doi:10.1038/nm.1979 · Cited by 1,165
Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia
Raaijmakers, M. H. G. P., Mukherjee, S., Guo, S., Zhang, S., Kobayashi, T., Schoonmaker, J. A., Ebert, B. L., Al-Shahrour, F., Hasserjian, R. P., Scadden, E. O., et al. (2010) · Nature · doi:10.1038/nature08851 · Cited by 1,115
Exerkines in health, resilience and disease
Chow, L. S., Gerszten, R. E., Taylor, J. M., Pedersen, B. K., van Praag, H., Trappe, S., Febbraio, M. A., Galis, Z. S., Gao, Y., Haus, J. M., et al. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00641-2 · Cited by 927
Role of transforming growth factor-β superfamily signaling pathways in human disease
Gordon, K. J., & Blobe, G. C. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.01.006 · Cited by 664
The Osteosarcoma Microenvironment: A Complex but Targetable Ecosystem
Corre, I., Verrecchia, F., Crenn, V., Rédiní, F., & Trichet, V. (2020) · Cells · doi:10.3390/cells9040976 · Cited by 494

See all 714

Authors: Janssens, K., ten Dijke, P., Janssens, S., & Van Hul, W.
Affiliations: University of Antwerp (BE)
Department of Molecular Cell Biology (P.t.D.), Leids Universitair Medisch Centrum, 2333 AL Leiden, The Netherlands;
University of Lausanne (CH)
Department of Medical Genetics (K.J., W.V.H.), University of Antwerp, 2610 Antwerp, Belgium;
ORCID: Janssens, Katrien
Janssens, Sophie
Venue: Endocrine Reviews
Publisher: The Endocrine Society
Published: 2005-10-01
Volume: 26
Issue: 6
Pages: 743-774
ISSN: 0163-769X (ISSN-L)
1945-7189
DOI: 10.1210/er.2004-0001
OpenAlex: W2144206769
Cited by: 710
References: 408
Citations by year: 2026: 12 · 2025: 26 · 2024: 24 · 2023: 35 · 2022: 30 · 2021: 30 · 2020: 27 · 2019: 22 · 2018: 23 · 2017: 34 · 2016: 37 · 2015: 26 · 2014: 46 · 2013: 57 · 2012: 47
FWCI: 2.60
Type: journal article
Language: en
Open access: closed
Locations: Endocrine Reviews (publishedVersion)
PubMed (publishedVersion)
Ghent University Academic Bibliography (Ghent University) (submittedVersion)
Funders: Fonds Wetenschappelijk Onderzoek
Universiteit Antwerpen
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Keywords: TGF-β1, bone metabolism, osteoblasts, osteoclasts, bone remodeling, bone resorption, bone formation, cartilage, skeletal development, cytokine signaling
MeSH terms: Animals, Bone and Bones, Bone Development, Bone Resorption, Cells, Cultured, Humans, Osteoblasts, Osteoclasts, Phenotype, Stem Cells, Signal Transduction, Transforming Growth Factor beta, Protein Isoforms, Transforming Growth Factor beta1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Transforming Growth Factor-β1 to the Bone

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks